Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy

Véronique Nève, Jean-Louis Edmé, Régis Matran
European Respiratory Journal 2014 44: 1361-1363; DOI: 10.1183/09031936.00043214
Véronique Nève
Service d’Explorations Fonctionnelles Respiratoires, CHRU de Lille, and Univ. Lille Nord de France, UDSL, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: veronique.neve@chru-lille.fr
Jean-Louis Edmé
Service d’Explorations Fonctionnelles Respiratoires, CHRU de Lille, and Univ. Lille Nord de France, UDSL, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Régis Matran
Service d’Explorations Fonctionnelles Respiratoires, CHRU de Lille, and Univ. Lille Nord de France, UDSL, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

In Duchenne muscular dystrophy (DMD), progressive weakness of the respiratory muscles leads to a restrictive ventilatory defect contributing to early morbidity and mortality. We have recently shown by a longitudinal assessment of vital capacity and sniff nasal inspiratory pressure (SNIP) in young DMD children that SNIP was an earlier marker of decline in respiratory muscle strength than vital capacity [1]. However, early involvement of the expiratory muscles is a characteristic feature of DMD, as shown by the earlier decrease in expiratory (PEmax) than inspiratory maximal pressure (PImax) [2]. In the absence of bronchial obstruction, peak expiratory flow (PEF) reflects maximal expiratory muscle strength [3]. In patients with respiratory weakness, PEF is reduced and correlated with PEmax [4]. Recently, it was shown that DMD patients on a 1-year idebenone treatment improved in expiratory muscle strength (evaluated by PEF) while patients on placebo deteriorated [5]. No difference between treatments groups were observed for measures such as vital capacity [6], suggesting that PEF could be used as an outcome parameter to assess the effect of early therapeutic interventions on respiratory muscle strength in DMD. As candidate drugs for the treatment of DMD enter clinical trials, it is important to determine the natural evolution of pulmonary function parameters that could be used as outcome measures for efficacy studies in DMD children. However, to our knowledge, there are no data on the natural evolution of PEF in young DMD children and there is no information on the age of PEF decline compared with the age of SNIP decline. Therefore, we aimed to assess the PEF and SNIP change with age in glucocorticoid-naïve DMD children in order: 1) to document the natural evolution of PEF measurement; and 2) to identify the ages of decline in PEF and SNIP in DMD children.

A 3-year, prospective follow-up of SNIP and PEF at 6-month intervals was performed in 33 DMD, steroid-naïve 5–20-year-olds [1]. Vital capacity and PImax were also assessed [1].

Inclusion criteria and SNIP assessments have been described previously [1]. At least 10 (most often 15–20) maximal sniffs, performed from functional residual capacity, were obtained. PEF was obtained from flow–volume curve data (Masterscreen Pneumo; Erich Jaeger, Wurzburg, Germany) as the maximum expiratory flow achieved from a maximum forced expiration, starting without hesitation from the point of maximal lung inflation. The largest value from at least three acceptable manoeuvres was recorded [7]. Results were expressed as z-scores [8, 9]. Median (interquartile range (IQR)) is presented for continuous variables and percentages for categorical variables. At inclusion, for SNIP, the within-session repeatability was evaluated by the coefficient of variation (CoV), and for PEF, by the difference between the largest and the next largest manoeuvre [7]. A nonlinear mixed model was used to analyse the change of PEF and SNIP versus a broken function of age that took 0 before the knot and subject’s age after the knot [10]; the knot position was optimised by the smallest Akaike information criterion. At this optimal knot, intercept (no change) and slope (decrease) was estimated; comparison between the age of the knot for SNIP and that for PEF was performed on the z-score value of these two parameters.

The full DMD characteristics were described in our previous study; ambulation was lost at a median age of 9.4 years (IQR 8.3–10.4 years). Scoliosis developed in 61% of DMD during the follow-up; spine fusion was performed in 36% of the non-ambulatory patients with spinal curvature >30° at a median age of 13.2 years (IQR 12.5–13.8 years). Nocturnal non-invasive ventilation (NIV) had been initiated in one subject before the beginning of the study.

At inclusion, median age was 11.0 years (range 5.0–16.7 years), median height was 136 cm (range 103–170 cm) and median body mass index (BMI) z-score was -0.10 (range -4.80–6.30) [11]. Baseline median SNIP z-score was −2.20 (range -4.24– -0.91; 79% of children had values < −1.64) while baseline median PEF z-score was −1.20 (range -3.94–0.58; 34% of children had values < −1.64). SNIP baseline median CoV was 8% (IQR 6–11%). Median difference between the largest two PEFs was 0.050 L·s−1 (IQR 0.040–0.190 L·s−1) or 2% of highest PEF (IQR 1–6%).

The model (broken function of age) that best fitted SNIP and PEF values in longitudinal analysis is shown in figure 1, demonstrating an earlier decline in SNIP than PEF values (from 9.72 years of age (95% CI 8.89–10.55 years) and 11.45 years of age (95% CI 11.09–11.81); p<0.0001).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Analysis of longitudinal data. The model that best fitted the data predicted that sniff nasal inspiratory pressure (SNIP) values plateaued at a z-score of −1.6956 until the age of 9.72 years then declined by 0.2652 per year of age, while peak expiratory flow (PEF) z-scores plateaued at −1.1686 until 11.45 years then declined by 0.6828 per year. The SNIP values therefore declined before PEF values.

Although early involvement of the expiratory muscles is a characteristic feature of DMD (as shown by the earlier decrease in PEmax than PImax [2] or values of gastric pressure during cough being below normal values in patients as early as 8 years of age [12]), this longitudinal assessment of SNIP and PEF shows an earlier decline in SNIP than PEF in DMD children.

PEF baseline values in the present study showed a good repeatability (as the largest two blows were reproducible to within 0.670 L.s−1 [7] and as median difference between the two best measurements was 2% of the best) and appeared reliable. Our transverse data at inclusion showed that a significant decrease in inspiratory muscle pressure (SNIP z-score < −1.64) was already present in a majority (79%) of children (median age 11 years) while only a minority them (34%) of experienced a significant PEF decrease. As a result, median SNIP was already below normal values (z-score −2.20) while median PEF remained within normal values.

Our longitudinal data analysis adds that the decline in SNIP values began 1.73 years earlier than that of PEF.

As PEF depends not only on expiratory strength but also on inspiratory effort [13], we suggest that PEF may be relatively preserved as long as the inspiratory muscle function, the speed of inspiration (as evaluated by SNIP), the vital and inspiratory capacities, and the thoracopulmonary elastic recoil are only moderately affected [14]. We also suggest that with deterioration of both inspiratory muscle strength and vital capacity, after 11 years of age (the same broken-line model applied to the longitudinal assessment of vital capacity showed that vital capacity values were below the lower limit of normal after 11 years of age), DMD subjects may no longer be able to perform fast inspirations reaching 85–95% of their inspiratory capacity, producing increases in the elastic recoil of the lung and chest wall and, therefore, greater PEF values, and enhancing expiratory muscle pressure during the subsequent expiration [15].

SNIP is useful in the detection of inspiratory strength decline in young DMD cases when vital capacity remains within normal values. It has the advantage of being obtainable from DMD subjects as young as 5 years and could be suitable as a sensitive secondary outcome measure specifically evaluating respiratory muscle strength in young children up to 10 years of age. SNIP may also provide information regarding the severity of the clinical DMD subphenotype, as children requiring earlier NIV exhibit an earlier decrease in SNIP [1].

In conclusion, although PEF was shown to be a sensitive parameter to monitor the effect of therapeutic intervention on respiratory muscle strength in 8–16-year-old DMD children [6], our data show that SNIP decline occurred before PEF decline in young DMD children and that SNIP decline is therefore an earlier sign of the decline of respiratory muscle strength in DMD than the decline of PEF.

Footnotes

  • Support statement: The research was supported by a grant from the French Ministry of Health (PHRC number 2001 1937).

  • Conflict of interest: None declared.

  • Received March 6, 2014.
  • Accepted June 30, 2014.
  • ©ERS 2014

References

  1. ↵
    1. Nève V,
    2. Cuisset JM,
    3. Edmé JL,
    4. et al
    . SNIP interest in the longitudinal assessment of young Duchenne muscular dystrophy children. Eur Respir J 2013; 42: 671–680.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hahn A,
    2. Bach JR,
    3. Delaubier A,
    4. et al
    . Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1997; 78: 1–6.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Suarez AA,
    2. Pessolano FA,
    3. Monteiro SG,
    4. et al
    . Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil 2002; 81: 506–511.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Vincken WG,
    2. Elleker MG,
    3. Cosio MG
    . Flow–volume loop changes reflecting respiratory muscle weakness in chronic neuromuscular disorders. Am J Med 1987; 83: 673–680.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Buyse GM,
    2. Goemans N,
    3. van den Hauwe M,
    4. et al
    . Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol 2013; 48: 912–920.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Buyse GM,
    2. Goemans N,
    3. van den Hauwe M,
    4. et al
    . Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial. Neuromuscul Disord 2011; 21: 396–405.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. et al
    . Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Stefanutti D,
    2. Fitting JW
    . Sniff nasal inspiratory pressure. Reference values in Caucasian children. Am J Respir Crit Care Med 1999; 159: 107–111.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Zapletal A,
    2. Paul T,
    3. Samanek N
    . Die Bedeutung heutiger Methoden der Lungen-funktionsdiagnostik zur Feststellung einer Obstruktion der Atemwege bei Kindern und Jugendlichen [Significance of contemporary methods of lung function testing for the detection of airway obstruction in children and adolescents]. Z Erkr Atmungsorgane 1977; 149: 343–371.
    OpenUrlPubMed
  10. ↵
    1. Robbins KR,
    2. Saxton AM
    . , Southern LL. Estimation of nutrient requirements using broken-line regression analysis. J Anim Sci 2006; 84: Suppl., E155–E165.
    OpenUrlPubMed
  11. ↵
    1. Cole TJ,
    2. Bellizzi MC,
    3. Flegal KM,
    4. et al
    . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240–1243.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Nicot F,
    2. Hart N,
    3. Forin V,
    4. et al
    . Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med 2006; 174: 67–74.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Tzelepis GE,
    2. Zakynthinos S,
    3. Vassilakopoulos T,
    4. et al
    . Inspiratory maneuver effects on peak expiratory flow. Role of lung elastic recoil and expiratory pressure. Am J Respir Crit Care Med 1997; 156: 1399–1404.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Pedersen OF
    . The Peak Flow Working Group: physiological determinants of peak expiratory flow. Eur Respir J 1997; 10: Suppl. 24, 11s–16s.
    OpenUrl
  15. ↵
    1. Omar T,
    2. Alawadhi H,
    3. Soubani AO,
    4. et al
    . Peak expiratory flow with or without a brief postinspiratory pause. Chest 2005; 128: 442–445.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 44 Issue 5 Table of Contents
European Respiratory Journal: 44 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy
Véronique Nève, Jean-Louis Edmé, Régis Matran
European Respiratory Journal Nov 2014, 44 (5) 1361-1363; DOI: 10.1183/09031936.00043214

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy
Véronique Nève, Jean-Louis Edmé, Régis Matran
European Respiratory Journal Nov 2014, 44 (5) 1361-1363; DOI: 10.1183/09031936.00043214
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Mitochondrial DNA as biomarker of survival in RA-ILD
  • Lung transplantation for cystic fibrosis before and after availability of elexacaftor/tezacaftor/ivacaftor
  • Elexacaftor-tezacaftor-ivacaftor and circulating neutrophil counts in CF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society